Cynata secures European paediatric regulatory approval
Cynata Therapeutics (ASX:CYP) has received a positive opinion from the European Medicines Agency’s paediatric committee.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Cynata Therapeutics (ASX:CYP) has received a positive opinion from the European Medicines Agency’s paediatric committee.
Firebrick Pharma (ASX:FRE) said its patent covering the composition of Nasodine nasal spray has been granted in New Zealand.
Cancer diagnostics company Pacific Edge (ASX:PEB) has finalised a NZ$36.1 million capital raising campaign.
Imagion Biosystems (ASX:IBX) achieved a regulatory milestone following formal Investigational New Drug clearance from the US FDA.
4DMedical (ASX:4DX) has launched CLEAR, a clinical evidence programme designed to fast-track its proprietary CT:VQ technology.
Memphasys (ASX:MEM) has secured its first commercial partnership in Southeast Asia.
ReNerve (ASX:RNV) entered an exclusive three-year deal with Swedish Trading to commercialise its NervAlign nerve repair products.
4DMedical (ASX:4DX) announced a binding agreement to acquire the Austrian-based medical technology company contextflow.
Pro Medicus (ASX:PME) has secured two major contract wins in the United States, totalling $44 million.
Paragon Care (ASX:PGC) issued an update regarding its financial exposure to the receivership of the Infinity Retail Pharmacy Group.
PolyNovo (ASX:PNV) has finalised the clinical study report for its US pivotal randomised controlled trial evaluating NovoSorb BTM for full-thickness burns.
4DMedical (ASX:4DX) has secured a commercial agreement with SimonMed Imaging.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade